Suzhou Zelgen Biopharmaceuticals Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, and distribution of medicin...
ZeJing Pharma's Thyroid Cancer Treatment Trial Meets Primary Endpoint
3 Asian Stocks Estimated To Be Undervalued By Up To 49.6%
Zelgen: The Phase III clinical trial of Hydrochloride Gikaxitin Tablets for the treatment of active ankylosing spondylitis has reached the primary efficacy endpoint
3 Global Growth Companies With High Insider Ownership Expecting 38% Revenue Growth
Zelgen: Injectable ZGGS34 has received approval for clinical trials
Zelgen: Injectable ZG006 initiates key clinical trials and completes enrollment of the first subject